Literature DB >> 11596027

Comorbidity and survival of elderly head and neck carcinoma patients.

B C Reid1, A J Alberg, A C Klassen, J M Samet, R G Rozier, I Garcia, D M Winn.   

Abstract

BACKGROUND: Alcohol and tobacco, the primary etiologic agents for head and neck carcinoma (HNCA), cause other chronic diseases and may contribute to the high prevalence of comorbid conditions and generally poor survival of persons with HNCA.
METHODS: The authors explored the prognostic role of comorbidity in persons with HNCA using Health Care Finance Administration Medicare (HCFA) files linked with the appropriate files of the Surveillance, Epidemiology, and End Results (SEER) Program. The Charlson comorbidity index was applied to in-patient data from the HCFA files. The SEER data were used to ascertain survival and identify persons with HNCA diagnosed from 1985 to 1993 (n = 9386).
RESULTS: In a proportional hazards regression model adjusted for age and historic stage at diagnosis, race, gender, marital status, socioeconomic status, histologic grade, anatomic site, treatment, and pre-1991 diagnosis, Charlson index scores of 0, 1, and 2+ had estimated relative hazards (RHs) with 95 confidence intervals (CIs) of 1.00, 1.33 (95% CI, 1.21-1.47), and 1.83 (95% CI, 1.64-2.05), respectively (P value for trend < 0.0001). The adjusted RH for a Charlson index score of 1 or more compared with 0, using stratified models, was found to be greater in whites (RH, 1.55; 95% CI, 1.43-1.67) than blacks (RH, 1.24; 95% CI, 0.96-1.60), local (RH, 1.72; 95% CI, 1.50-1.96) versus distant stage (RH, 1.25; 95% CI, 1.00-1.56), and age 65-74 years (RH, 1.53; 95% CI, 1.38-1.69) versus age 85+ years (RH, 1.42; 95% CI, 1.09-1.84).
CONCLUSIONS: This study establishes comorbidity as a predictor of survival in an elderly HNCA population and lends support to the inclusion of comorbidity assessment in prognostic staging of patients with HNCA diagnosed after 65 years of age. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11596027     DOI: 10.1002/1097-0142(20011015)92:8<2109::aid-cncr1552>3.0.co;2-m

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  30 in total

Review 1.  Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.

Authors:  Jay F Piccirillo; Anna Vlahiotis
Journal:  Curr Oncol Rep       Date:  2006-03       Impact factor: 5.075

2.  Disparities in oral and pharyngeal cancer incidence, mortality and survival among black and white Americans.

Authors:  Douglas E Morse; A Ross Kerr
Journal:  J Am Dent Assoc       Date:  2006-02       Impact factor: 3.634

Review 3.  Management of head and neck cancer in elderly patients.

Authors:  Yassine Lalami; Gilberto de Castro; Chantal Bernard-Marty; Ahmad Awada
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

4.  Elderly patients at higher risk of laryngeal carcinoma recurrence could be identified by a panel of two biomarkers (nm23-H1 and CD105) and pN+ status.

Authors:  Andrea Lovato; Gino Marioni; Enzo Manzato; Claudia Staffieri; Luciano Giacomelli; Giovanni Ralli; Alberto Staffieri; Stella Blandamura
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-04       Impact factor: 2.503

5.  Patterns of care in older patients with squamous cell carcinoma of the head and neck: a surveillance, epidemiology, and end results-medicare analysis.

Authors:  Noam A VanderWalde; Anne-Marie Meyer; Huan Liu; Seth D Tyree; Leah L Zullig; William R Carpenter; Carol D Shores; Mark C Weissler; David N Hayes; Mary Fleming; Bhishamjit S Chera
Journal:  J Geriatr Oncol       Date:  2013-07       Impact factor: 3.599

6.  Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010.

Authors:  Sophie Cai; Theodore S Hong; Saveli I Goldberg; Carlos Fernandez-del Castillo; Sarah P Thayer; Cristina R Ferrone; David P Ryan; Lawrence S Blaszkowsky; Eunice L Kwak; Christopher G Willett; Keith D Lillemoe; Andrew L Warshaw; Jennifer Y Wo
Journal:  Cancer       Date:  2013-09-04       Impact factor: 6.860

7.  Trends in chemoradiation use in elderly patients with head and neck cancer: Changing treatment patterns with cetuximab.

Authors:  Shrujal S Baxi; Caitriona O'Neill; Eric J Sherman; Coral L Atoria; Nancy Y Lee; David G Pfister; Elena B Elkin
Journal:  Head Neck       Date:  2015-06-26       Impact factor: 3.147

Review 8.  Associations of social networks with cancer mortality: a meta-analysis.

Authors:  Martin Pinquart; Paul R Duberstein
Journal:  Crit Rev Oncol Hematol       Date:  2009-07-14       Impact factor: 6.312

9.  Treatment patterns, outcomes and costs among elderly patients with chronic myeloid leukaemia: a population-based analysis.

Authors:  Joseph Menzin; Kathleen Lang; Craig C Earle; Alastair Glendenning
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

10.  Multilevel Associations Between Patient- and Hospital-Level Factors and In-Hospital Mortality Among Hospitalized Patients With Head and Neck Cancer.

Authors:  Eric Adjei Boakye; Nosayaba Osazuwa-Peters; Betty Chen; Miao Cai; Betelihem B Tobo; Sai D Challapalli; Paula Buchanan; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-05-01       Impact factor: 6.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.